Jeffrey Zekaukas
Stock Analyst at JP Morgan
(1.57)
# 3,254
Out of 4,876 analysts
21
Total ratings
35.71%
Success rate
-0.17%
Average return
Main Sectors:
Stocks Rated by Jeffrey Zekaukas
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MOS The Mosaic Company | Maintains: Overweight | $29 → $35 | $35.32 | -0.91% | 5 | May 9, 2025 | |
EMN Eastman Chemical Company | Downgrades: Neutral | $112 → $76 | $76.21 | -0.28% | 4 | Apr 28, 2025 | |
ECL Ecolab | Downgrades: Neutral | $200 → $220 | $267.45 | -17.74% | 5 | Feb 14, 2024 | |
LYB LyondellBasell Industries | Upgrades: Overweight | $95 → $100 | $58.67 | +70.44% | 3 | Feb 5, 2024 | |
AVY Avery Dennison | Maintains: Overweight | $185 → $218 | $175.63 | +24.12% | 2 | Feb 1, 2024 | |
LLY Eli Lilly and Company | Maintains: Equal-Weight | $148 → $157 | $775.45 | -79.75% | 2 | Aug 14, 2020 |
The Mosaic Company
May 9, 2025
Maintains: Overweight
Price Target: $29 → $35
Current: $35.32
Upside: -0.91%
Eastman Chemical Company
Apr 28, 2025
Downgrades: Neutral
Price Target: $112 → $76
Current: $76.21
Upside: -0.28%
Ecolab
Feb 14, 2024
Downgrades: Neutral
Price Target: $200 → $220
Current: $267.45
Upside: -17.74%
LyondellBasell Industries
Feb 5, 2024
Upgrades: Overweight
Price Target: $95 → $100
Current: $58.67
Upside: +70.44%
Avery Dennison
Feb 1, 2024
Maintains: Overweight
Price Target: $185 → $218
Current: $175.63
Upside: +24.12%
Eli Lilly and Company
Aug 14, 2020
Maintains: Equal-Weight
Price Target: $148 → $157
Current: $775.45
Upside: -79.75%